AEON Biopharma, Inc. - CL A (AEON)

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
9.57M
Holdings value Q3 2024
$10.1M
Value change Q3 2024
+$4.02M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
30
Number of buys Q3 2024
18
Number of sells Q3 2024
-10
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 9.57M $10.1M +$4.02M $1.05 30
2024 Q2 9.42M $8.73M -$432K $1.05 25
2024 Q1 9.47M $103M +$9.34M $11.60 25
2023 Q4 8.67M $56.8M +$26.5M $7.20 21
2023 Q3 4.75M $25.9M +$24.4M $5.60 15